Methylglyoxal

Chemical structure

Gaseous methylglyoxal has two carbonyl groups: an aldehyde and a ketone. In the presence of water, it exists as hydrates and oligomers. The formation of these hydrates is indicative of the high reactivity of MGO, which is relevant to its biological behavior.

Biochemistry

Biosynthesis and biodegradation

In organisms, methylglyoxal is formed as a side-product of several metabolic pathways. Methylglyoxal mainly arises as side products of glycolysis involving glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. It is also thought to arise via the degradation of acetone and threonine. It may form from 3-aminoacetone, which is an intermediate of threonine catabolism, as well as through lipid peroxidation. However, the most important source is glycolysis. Here, methylglyoxal arises from nonenzymatic phosphate elimination from glyceraldehyde phosphate and dihydroxyacetone phosphate (DHAP), two intermediates of glycolysis. This conversion is the basis of a potential biotechnological route to the commodity chemical 1,2-propanediol.

Since methylglyoxal is highly cytotoxic, several detoxification mechanisms have evolved. One of these is the glyoxalase system. Methylglyoxal is detoxified by glutathione. Glutathione reacts with methylglyoxal to give a hemithioacetal, which converted into S-D-lactoyl-glutathione by glyoxalase I. This thioester is hydrolyzed to D-lactate by glyoxalase II.

Biochemical function

Methylglyoxal is involved in the formation of advanced glycation end products (AGEs). In this process, methylglyoxal reacts with free amino groups of lysine and arginine and with thiol groups of cysteine forming AGEs. Argpyrimidine is one example. Histones are also heavily susceptible to modification by methylglyoxal and these modifications are elevated in breast cancer.

DNA damages are induced by reactive carbonyls, principally methylglyoxal and glyoxal, at a frequency similar to that of oxidative DNA damages. Such damage, referred to as DNA glycation, can cause mutation, breaks in DNA and cytotoxicity. In humans, a protein DJ-1 (also named PARK7), has a key role in the repair of glycated DNA bases.

Biomedical aspects

Due to increased blood glucose levels, methylglyoxal has higher concentrations in diabetics and has been linked to arterial atherogenesis. Damage by methylglyoxal to low-density lipoprotein through glycation causes a fourfold increase of atherogenesis in diabetics. Methylglyoxal binds directly to the nerve endings and by that increases the chronic extremity soreness in diabetic neuropathy.

Occurrence, other

Methylglyoxal is a component of some kinds of honey, including manuka honey; it appears to have activity against E. coli and S. aureus and may help prevent formation of biofilms formed by P. aeruginosa.

Research suggests that methylglyoxal contained in honey does not cause an increased formation of advanced glycation end products (AGEs) in healthy persons.

References

References

1. (2010). "Carbohydrates as Organic Raw Materials".
2. (2006). "Oligomer Formation in Evaporating Aqueous Glyoxal and Methyl Glyoxal Solutions". Environmental Science & Technology.
3. (1995). "Methylglyoxal and regulation of its metabolism in microorganisms". Adv. Microb. Physiol..
4. (2012). "Aristolochic acid-induced accumulation of methylglyoxal and Nε-(carboxymethyl)lysine: an important and novel pathway in the pathogenic mechanism for aristolochic acid nephropathy". Biochem Biophys Res Commun.
5. Sullivan, Carl J.. (2018). "Propanediols".
6. Thornalley PJ. (2003). "Glyoxalase I—structure, function and a critical role in the enzymatic defence against glycation". Biochem. Soc. Trans..
7. Vander Jagt DL. (1993). "Glyoxalase II: molecular characteristics, kinetics and mechanism". Biochem. Soc. Trans..
8. (2019). "Methylglyoxal, a Potent Inducer of AGEs, Connects between Diabetes and Cancer". Diabetes Research and Clinical Practice.
9. (September 2018). "Methylglyoxal-derived posttranslational arginine modifications are abundant histone marks". Proc Natl Acad Sci USA.
10. (March 2019). "Reversible histone glycation is associated with disease-related changes in chromatin architecture". Nat Commun.
11. (1999). "Methylglyoxal Modification of Protein". Journal of Biological Chemistry.
12. Richarme G, Liu C, Mihoub M, Abdallah J, Leger T, Joly N, Liebart JC, Jurkunas UV, Nadal M, Bouloc P, Dairou J, Lamouri A. Guanine glycation repair by DJ-1/Park7 and its bacterial homologs. Science. 2017 Jul 14;357(6347):208-211. doi: 10.1126/science.aag1095. Epub 2017 Jun 8. PMID 28596309
13. Rabbani N. (May 26, 2011). "Glycation of LDL by methylglyoxal increases arterial atherogenicity. A possible contributor to increased risk of cardiovascular disease in diabetes". Diabetes.
14. [http://www.deutsche-apotheker-zeitung.de/spektrum/news/2012/05/21/methylglyoxal-verstaerkt-den-schmerz/7284.html Spektrum: Diabetische Neuropathie: Methylglyoxal verstärkt den Schmerz: DAZ.online] {{Webarchive. link. (2015-10-10 . Deutsche-apotheker-zeitung.de (2012-05-21). Retrieved on 2012-06-11.)
15. (2012). "Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy". Nature Medicine.
16. (2014). "Antimicrobial properties of honey.". [[American Journal of Therapeutics]].
17. (April 2010). "Demonstrating the safety of manuka honey UMF® 20+ in a human clinical trial with healthy individuals". Br J Nutr.
18. (October 2013). "Metabolic transit of dietary methylglyoxal". J Agric Food Chem.